E-resources
-
Ananthakrishnan, Ashwin N.; Luo, Chengwei; Yajnik, Vijay; Khalili, Hamed; Garber, John J.; Stevens, Betsy W.; Cleland, Thomas; Xavier, Ramnik J.
Cell host & microbe, 05/2017, Volume: 21, Issue: 5Journal Article
The gut microbiome plays a central role in inflammatory bowel diseases (IBDs) pathogenesis and propagation. To determine whether the gut microbiome may predict responses to IBD therapy, we conducted a prospective study with Crohn’s disease (CD) or ulcerative colitis (UC) patients initiating anti-integrin therapy (vedolizumab). Disease activity and stool metagenomes at baseline, and weeks 14, 30, and 54 after therapy initiation were assessed. Community α-diversity was significantly higher, and Roseburia inulinivorans and a Burkholderiales species were more abundant at baseline among CD patients achieving week 14 remission. Several significant associations were identified with microbial function; 13 pathways including branched chain amino acid synthesis were significantly enriched in baseline samples from CD patients achieving remission. A neural network algorithm, vedoNet, incorporating microbiome and clinical data, provided highest classifying power for clinical remission. We hypothesize that the trajectory of early microbiome changes may be a marker of response to IBD treatment. Display omitted •Stool metagenomes of IBD patients starting biologic therapy were prospectively assessed•Higher abundance of butyrate producers at baseline in therapy-responsive CD patients•Baseline enrichment of 13 microbial pathways in therapy-responsive CD patients•Early microbial changes at week 14 persist up to 1 year in responders Gut microbiome may predict responses to clinical therapy. Ananthakrishnan et al. conducted a prospective study with IBD patients initiating anti-integrin therapy. Higher abundance of butyrate producers and enrichment of 13 microbial pathways at baseline in therapy-responsive CD patients was observed. Early microbial changes persist up to 1 year in responders.
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.